Form 4: Singular Genomics Systems Director Acquires Stock Options
SEC Form 4 Filing
Marcia Eisenberg, a director at Singular Genomics Systems, acquired stock options exercisable for 55,500 shares of common stock.
Summary
- On May 29, 2024, Marcia Eisenberg, a director of Singular Genomics Systems, Inc. [OMIC], acquired stock options.
- The options are exercisable for 55,500 shares of common stock at a price of $0.372 per share.
- The options vest and become exercisable upon the earlier of the 2025 Annual Meeting of Stockholders or May 29, 2025.
- Following the transaction, Eisenberg directly owns options for 55,500 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding stock option grants, which is neutral in sentiment.
Industry Context
This is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the holdings of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding director compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of transaction: Marcia Eisenberg acquired stock options. |
| 05/29/2025 | Options vest and become exercisable upon the earlier of the 2025 Annual Meeting of Stockholders or this date. |
| 05/29/2034 | Expiration date of the stock options. |
| 05/31/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.